Health
Goodpath Expands Access to Obesity Management Care and Medications Through New Transparent Offering
Goodpath, the virtual integrative care clinic for chronic conditions, today announced a new access pathway for obesity management care and medications, if clinically appropriate. The pathway is designed to make evidence-based weight management more financially sustainable for employers. Goodpath's solution simplifies access to FDA-approved medications for obesity care, including Eli Lilly and Company's obesity management medicine, and reduces cost barriers for employers and members at a time of
About this update from Eli Lilly And Company
[{"type":"text","content":"New approach connects members to affordable, clinically guided obesity-management care","length":86,"tagName":"p","attribs":{}},{"type":"text","content":"BOSTON, Nov. 21, 2025 /PRNewswire/ -- Goodpath, the virtual integrative care clinic for chronic conditions, today announced a new access pathway for obesity management care and medications, if clinically appropriate. The pathway is designed to make evidence-based weight management more financially sustainable for employers. Goodpath's solution simplifies access to FDA-approved medications for obesity care, including Eli Lilly and Company's obesity management medicine, and reduces cost barriers for employers and members at a time of record demand and rising expenses across the obesity-care market.","length":611,"tagName":"p"},{"type":"image","alt":"Goodpath (PRNewsfoto/Goodpath)","displaySize":"","headline":null,"caption":"Goodpath (PRNewsfoto/Goodpath)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":96,"url":"https://media.zenfs.com/en/prnewswire.com/7308b39e863b8fb39723d330a3529d6b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zahke9QG0V_0WZ9s_SJHFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7308b39e863b8fb39723d330a3529d6b","width":400,"height":96}},"href":"https://mma.prnewswire.com/media/2750064/goodpath_logo_2021_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"By removing rebates and hidden fees, the model makes obesity management medication costs more predictable for employers. The program has the potential to reduce obesity management medication expenses by 35% or more for employers, while helping more people begin and sustain treatment. Grounded in clinical evidence, Goodpath's approach ensures that these medicines are used where they work best: paired with multidisciplinary clinical and behavioral support that addresses nutrition, movement, sleep, mental health, and related conditions. Each member is guided by a Goodpath care team spanning more than 20 medical specialties to promote safe, effective, and lasting outcomes.","length":681,"tagName":"p"},{"type":"text","content":""Obesity management medications have changed what's possible for people struggling with weight, but access has become the major barrier," said Bill Gia...